Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Assessment of Efficacy Evidence for Approvals of Novel Drugs in China Between 2018 and 2022.

Autor: Xu Y; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.; Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration, Beijing, China., Li X; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.; Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration, Beijing, China.; College of Pharmaceutical Sciences, Soochow University, Suzhou, China., Guo Q; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.; Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration, Beijing, China., Chen Q; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.; Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration, Beijing, China., Su M; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.; Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration, Beijing, China.; College of Pharmaceutical Sciences, Soochow University, Suzhou, China., Zhang X; College of Pharmaceutical Sciences, Soochow University, Suzhou, China., Yang Y; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.; Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration, Beijing, China.

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Dec 10. Date of Electronic Publication: 2024 Dec 10.